Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Pediatric NAFLD
NCT04109742Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Dec 2019
- Primary completion
- Apr 2020
01
Overview
Phase 2, randomised, double-blind trial in non-alcoholic fatty liver disease (NAFLD) and Nonalcoholic steatohepatitis (NASH), sponsored by Columbia University. Planned start Dec 2019; status: withdrawn.
02
Conditions
non-alcoholic fatty liver disease (NAFLD)Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04109742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04109742.